Capsule Endoscopy Market Analysis, Size, Trends | Global | 2019-2025 | MedCore
- Year: 2019
- Scope: 2015-2025
- Region: Brazil, Canada, China, Europe, India, United States
- Pages: 149
- Type: MedCore
Capsule endoscopy was first introduced in the U.S. in 2001 by Given Imaging, an Israeli company based in Yokneam, Israel. Modeled after advanced missile guidance technology, capsule endoscopy allows patients to undergo diagnostic procedures without any of the discomfort associated with conventional endoscopies. These procedures are noninvasive and typically painless.
From 2001 to 2005, Given Imaging was the only company offering a capsule endoscopy product. After 2005, Olympus and Intromedic entered the market and began competing aggressively alongside Given
Imaging’s product. However, due to Given Imaging’s first mover advantage and established installed base, Olympus and Intromedic continue to experience challenges in regards to capturing market share, despite sustained progress being made within Europe in the last few years. In 2014, Given Imaging was acquired by Medtronic. Other Asian vendors, such as China’s Jinshan Science and Technology Co., have received mixed reviews from end users pertaining to the quality and reliability of their products, making it difficult for them to gain traction in European markets dominated by Medtronic, Olympus and Intromedic.
The camera capsule market is expected to grow in both the short and long-term; the current drivers are favorable reimbursement coupled with expanding indication for the esophageal and colonic markets. In the long-term, the camera capsule market is expected to benefit from ongoing research to address the major limitations of the device: its non-therapeutic nature and lack of control of the capsule passage. The research and development roadmap includes areas like biopsy, insufflation, passage control and chromoendoscop
Report Regional Coverage
Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:
- United States
- Europe (15 countries including: Germany, France, U.K., Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Finland, Norway and Sweden) Austria, Switzerland and Portugal)
Highly Detailed Segmentation
- Camera Capsule Market
- Workstation Market
- Data Recorder Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Capsule Endoscopy Market Share Insights
In the U.S. and European markets for the Capsule Endoscopy segment, the leading competitor is Medtronic. The company entered the market through its acquisition of Covidien in 2015, which acquired Given Imaging in 2013. Given Imaging was the first company to enter the capsule endoscopy market in 2001, allowing them to gain a significant first-mover advantage. The company’s extensive installed base allows it to retain existing customers and deter them from switching over to the only other major competitor in the market: Olympus. The company offers the PillCam™ SB 3, PillCam™ UGI and PillCam™ COLON 2 products. Capsule endoscopy remains a relatively niche market and Medtronic is expected to retain its market leading position, due to the strong historic presence in the space.
The second leading competitor in the Capsule Endoscopy market is Olympus. The company entered the market six years after Given Imaging launched the first capsule endoscopy product. Although it launched an initial aggressive marketing campaign, that at times included giving facilities workstations for free, which resulted in the company capturing market share away from Given Imaging, it was not able to continue this momentum. The company offers the ENDOCAPSULE™, a product that is very similar to the PillCam™ SB 3. Olympus is an established competitor in the GI device market. The company has an extensive network of marketing and sales personnel, as well as a good reputation with purchasing facilities. In 2018, Olympus saw a rise in its capital expenditures, due to new investments in the redevelopment of gastrointestinal endoscope product factories in Europe. Despite the dominant position of Medtronic, Olympus is expected to remain a notable competitor for the foreseeable future
The full list of companies can be seen below:
All Companies Analyzed in this Study
About Our In-Depth MedCore Research
- Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
- This MedCore is also found in the full report suite titled U.S. Market Report Suite for Gastrointestinal Endoscopic Devices – MedSuite
- Learn More about these product types
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.